XML 86 R75.htm IDEA: XBRL DOCUMENT v3.23.1
Stock Options and Restricted Stock - Summary of Activity for Stock Option Programs (Detail) - $ / shares
3 Months Ended 12 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Dec. 31, 2022
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Number of options beginning balance 1,061,849 1,111,687 1,111,687
Granted   0 0
Cancelled   (25,194) (26,093)
Exercised [1]   (44,583) (23,745)
Number of options ending balance 992,072 992,072 [2] 1,061,849
Options exercisable 729,812 548,426  
Exercise price per share, lower range limit beginning balance $ 2.14 $ 2.14 $ 2.14
Exercise price per share, upper range limit beginning balance 9.38 12.55 12.55
Exercise price per share, granted   0 0
Exercise price per share, lower range limit ending balance 2.14 2.14 [2] 2.14
Exercise price per share, upper range limit ending balance   9.38 [2] 9.38
Exercise price per share, option exercisable lower range limit     2.14
Exercise price per share, option exercisable upper range limit 9.38 9.38  
Weighted average exercise price, beginning balance 6.51 6.41 6.41
Weighted average exercise price, granted   0 0
Weighted average exercise price, cancelled   6.97 7.08
Weighted average exercise price, exercised   6.55 6.51 [1]
Weighted average exercise price, ending balance   6.53 [2] 6.51
Weighted average exercise price, options exercisable $ 6.50 6.51  
Minimum [Member]      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Exercise price per share, cancelled   4.89 4.89
Exercise price per share, exercised   4.89 4.89 [1]
Maximum [Member]      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Exercise price per share, cancelled   9.38 12.55
Exercise price per share, exercised   $ 7.25 $ 7.25 [1]
[1] The aggregate intrinsic value of exercised options, which represents the difference between the price of the Company’s common stock at the exercise date and the related exercise price of the underlying options, was $0.1 million and less than $0.1 million for the three months ended March 31, 2023 and 2022.
[2] The aggregate intrinsic value of outstanding options, which represents the difference between the price of the Company’s common stock at March 31, 2023 and the related exercise price of the underlying options, was $1.2 million for outstanding options and $0.9 million for exercisable options as of March 31, 2023. The remaining contractual life was 6.9 years for outstanding options and 6.6 years for exercisable options at March 31, 2023